Increased neointimal formation after surgical vein grafting in a murine model of type 2 diabetes

Circulation

Volumn 114, Issue SUPPL. 1, 2006, Pages

  Salzberg, Sacha P ^a   Filsoufi, Farzan ^a   Anyanwu, Anelechi ^a   Von Harbou, Kai ^a   Karlof, Eva ^a   Carpentier, Alain ^a   Dansky, Hayes M ^b   Adams, David H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Howard Hughes Medical Institute   (United States)

Author keywords

Coronary artery disease; Diabetes; Mouse; Neointima; Surgery

Indexed keywords

ALPHA ACTIN; COLLAGEN; ACTIN; CELL SURFACE RECEPTOR; ELASTIN; LEPTIN RECEPTOR;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EVALUATION; EXTRACELLULAR MATRIX; GROUPS BY AGE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INTIMA; MALE; MOLECULAR DYNAMICS; MORPHOMETRICS; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHYSIOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL ARTERY; SMOOTH MUSCLE FIBER; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; VEIN GRAFT; WILD TYPE; ABDOMINAL AORTA; ANIMAL; BIOPROSTHESIS; BIOSYNTHESIS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL TRANSPLANTATION; C57BL MOUSE; DISEASE MODEL; GENETICS; HETEROTOPIC TRANSPLANTATION; INFERIOR CAVA VEIN; METABOLISM; MOUSE MUTANT; PATHOLOGY; TRANSPLANTATION; VASCULAR SMOOTH MUSCLE;

ACTINS; ANIMALS; AORTA, ABDOMINAL; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; COLLAGEN; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ELASTIN; EXTRACELLULAR MATRIX; HYPERPLASIA; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, CELL SURFACE; TRANSPLANTATION, HETEROTOPIC; TUNICA INTIMA; VENA CAVA, INFERIOR;

EID: 33747171459     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.001339     Document Type: Article

References (19)

1. Loop FD, Lytle BW, Cosgrove DM. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314:1-6.
2. Luscher TF. Vascular biology of coronary bypass grafts. Curr Opin Cardiol. 1991;6:868-876.
3. Xu Q, Zhang Z, Davison F, Hu Y. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoEdeficient mice. Circ Res. 2003;93:76e-86e.
4. Newby AC, George SJ. Proliferation, migration, matrix turnover, and death of smooth muscle cells in native coronary and vein graft atherosclerosis. Curr Opin Cardiol. 1996;11:574-582.
5. Lorusso R, Pentiricci S, Raddino R, Scarabelli TM, Zambelli C, Villanacci V, Burattin A, Romanelli G, Casari S, Scelsi R, Giustina A. Influence of Type 2 Diabetes on Functional and Structural Properties of Coronary Artery Bypass Conduits. Diabetes. 2003 2003;52:2814-2820.
6. Morris JJ, Smith LR, Jones RH, Glower DD, Morris PB, Muhlbaier LH, Reves JG, Rankin JS. Influence of diabetes and mammary artery grafting on survival after coronary bypass. Circulation. 1991;84(5 Suppl):III275-III284.
7. Herlitz J, Brandrup-Wognsen G, Karlsson T, Karlson B, Haglid M, Sjöland H. Predictors of death and other cardiac events within 2 years after coronary artery bypass grafting. Cardiology. 1998;90:110-114.
8. Thourani VH, Weintraub WS, Stein B, Gebhart SSP, Craver JM, Jones EL, Guyton RA. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg. 1999;67:1045-1052.
9. Jonas M, Edelman ER, Groothuis A, Baker AB, Seifert P, Rogers C. Vascular Neointimal formation and signaling pathway activation in response to stent injury in insulin-resistant and diabetic animals. Circ Res. 2005;97:725-733.
10. Chua SC, Jr., Chung WK, Wu-Peng XS, Zhang Y, Liu S-M, Tartaglia L, Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science. 1996;271(5251):994-996.
11. Tennant M, McGeachie JK. Adaptive remodelling of smooth muscle in the neo-intima of vein-to-artery grafts in rats: a detailed morphometric analysis. Anat Embryol (Berl). 1993;187:161-166.
12. Hoch JR, Stark VK, Hullett DA, Turnipseed WD. Vein graft intimal hyperplasia: leukocytes and cytokine gene expression. Surgery. 1994;116:463-470; discussion 470-461.
13. Gil J, Wu HS. Applications of image analysis to anatomic pathology: realities and promises. Cancer Invest. 2003;21:950-959.
14. Zhang L, Hagen PO, Kisslo J, Peppel K, Freedman NJ. Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model. J Vasc Surg. 2002;36:824-832.
15. Diao Y, Xue J, Segal MS. A novel mouse model of autologous venous graft intimal hyperplasia. J Surg Res. 2005;126:106-113.
16. Zhang L, Peppel K, Brian L, Chien L, Freedman NJ. Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells. Arterioscler Thromb Vasc Biol. 2004;24:2277-2283.
17. Zou Y, Dietrich H, Hu Y, Metzler B, Wick G, Xu Q. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol. 1998;153:1301-1310.
18. Han DC, Isono M, Chen S, Casaretto A, Hong SW, Wolf G, Ziyadeh FN. Leptin stimulates type I collagen production in db/db mesangial cells: Glucose uptake and TGF-β type II receptor expression. Kidney Int. 2001;59:1315-1323.
19. Stephenson K, Tunstead J, Tsai A, Gordon R, Henderson S, Dansky HM. Neointimal formation after endovascular arterial injury is markedly attenuated in db/db mice. Arterioscler Thromb Vasc Biol. 2003;23:2027-2033.